Application of proteomics in biomarker discovery: A primer for the clinician

Physiological Research

Volumn 59, Issue 4, 2010, Pages 471-497

  Tambor, V ^a   Fucikova A ^a   Lenco J ^a   Kacerovsky M ^b,c   Rehacek V ^b,c   Stulik J ^a   Pudil, R ^b,c  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Biomarker; Mass spectrometry; Plasma; Proteomics

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN;

BLOOD; HUMAN; METHODOLOGY; PREDICTION AND FORECASTING; PROTEOMICS; REPRODUCIBILITY; REVIEW;

BIOLOGICAL MARKERS; BLOOD PROTEINS; HUMANS; PREDICTIVE VALUE OF TESTS; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 77958143488     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. ADDONA TA, ABBATIELLO SE, SCHILLING B, SKATES SJ, MANI DR, BUNK DM, SPIEGELMAN CH, ZIMMERMAN LJ, HAM AJ, KESHISHIAN H, HALL SC, ALLEN S, BLACKMAN RK, BORCHERS CH, BUCK C, CARDASIS HL, CUSACK MP, DODDER NG, GIBSON BW, HELD JM, HILTKE T, JACKSON A, JOHANSEN EB, KINSINGER CR, LI J, MESRI M, NEUBERT TA, NILES RK, PULSIPHER TC, RANSOHOFF D, RODRIGUEZ H, RUDNICK PA, SMITH D, TABB DL, TEGELER TJ, VARIYATH AM, VEGA-MONTOTO LJ, WAHLANDER A, WALDEMARSON S, WANG M, WHITEAKER JR, ZHAO L, ANDERSON NL, FISHER SJ, LIEBLER DC, PAULOVICH AG, REGNIER FE, TEMPST P, CARR SA: Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 27: 633-641, 2009.
2. ANDERSON L: Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol Lond 563: 23-60, 2005.
3. ANDERSON L, HUNTER CL: Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5: 573-588, 2006.
4. ANDERSON NL, ANDERSON NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867, 2002.
5. ANDERSON NL, ANDERSON NG, HAINES LR, HARDIE DB, OLAFSON RW, PEARSON TW: Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res 3: 235-244, 2004a.
6. ANDERSON NL, POLANSKI M, PIEPER R, GATLIN T, TIRUMALAI RS, CONRADS TP, VEENSTRA TD, ADKINS JN, POUNDS JG, FAGAN R, LOBLEY A: The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3: 311-326, 2004b.
7. ANDRIOLE GL, CRAWFORD ED, GRUBB RL 3RD, BUYS SS, CHIA D, CHURCH TR, FOUAD MN, GELMANN EP, KVALE PA, REDING DJ, WEISSFELD JL, YOKOCHI LA, O'BRIEN B, CLAPP JD, RATHMELL JM, RILEY TL, HAYES RB, KRAMER BS, IZMIRLIAN G, MILLER AB, PINSKY PF, PROROK PC, GOHAGAN JK, BERG CD: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360: 1310-1319, 2009.
8. ATKINSON AJ, COLBURN WA, DEGRUTTOLA VG: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95, 2001.
9. BANKS RE: Preanalytical influences in clinical proteomic studies: raising awareness of fundamental issues in sample banking. Clin Chem 54: 6-7, 2008.
10. BANTSCHEFF M, SCHIRLE M, SWEETMAN G, RICK J, KUSTER B: Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 389: 1017-1031, 2007.
11. BAZHIN AV, DALKE C, WILLNER N, ABSCHUTZ O, WILDBERGER HG, PHILIPPOV PP, DUMMER R, GRAW J, DE ANGELIS MH, SCHADENDORF D, UMANSKY V, EICHMULLER SB: Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy. Int J Cancer 124: 140-149, 2009.
12. BECK LH JR, BONEGIO RG, LAMBEAU G, BECK DM, POWELL DW, CUMMINS TD, KLEIN JB, SALANT DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009.
13. BERGGREN K, CHERNOKALSKAYA E, STEINBERG TH, KEMPER C, LOPEZ MF, DIWU Z, HAUGLAND RP, PATTON WF: Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 21: 2509-2521, 2000.
14. BERTH M, MOSER FM, KOLBE M, BERNHARDT J: The state of the art in the analysis of two-dimensional gel electrophoresis images. Appl Microbiol Biotechnol 76: 1223-1243, 2007.
15. BIJIAN K, MLYNAREK AM, BALYS RL, JIE S, XU Y, HIER MP, BLACK MJ, DI FALCO MR, LABOISSIERE S, ALAOUI-JAMALI MA: Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J Proteome Res 8: 2173-2185, 2009.
16. BJELLQVIST B, EK K, RIGHETTI PG, GIANAZZA E, GORG A, WESTERMEIER R, POSTEL W: Isoelectric focusing in immobilized pH gradients: principle, methodology and some applications. J Biochem Biophys Methods 6: 317-339, 1982.
17. BLAGOEV B, ONG SE, KRATCHMAROVA I, MANN M: Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat Biotechnol 22: 1139-1145, 2004.
18. BODNAR WM, BLACKBURN RK, KRISE JM, MOSELEY MA: Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J Am Soc Mass Spectrom 14: 971-979, 2003.
19. BOERSEMA PJ, AYE TT, VAN VEEN TA, HECK AJ, MOHAMMED S: Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates. Proteomics 8: 4624-4632, 2008.
20. BONDARENKO PV, CHELIUS D, SHALER TA: Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem 74: 4741-4749, 2002.
21. BROOKS SA, CARTER TM, ROYLE L, HARVEY DJ, FRY SA, KINCH C, DWEK RA, RUDD PM: Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Anticancer Agents Med Chem 8: 2-21, 2008.
22. BRUEGEL M, PLANERT M, BAUMANN S, FOCKE A, BERGH FT, LEICHTLE A, CEGLAREK U, THIERY J, FIEDLER GM: Standardized peptidome profiling of human cerebrospinal fluid by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Proteomics 72: 608-615, 2009.
23. CALLESEN AK, MADSEN JS, VACH W, KRUSE TA, MOGENSEN O, JENSEN ON: Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool? Proteomics 9: 1428-1441, 2009.
24. CANDIANO G, BRUSCHI M, MUSANTE L, SANTUCCI L, GHIGGERI GM, CARNEMOLLA B, ORECCHIA P, ZARDI L, RIGHETTI PG: Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25: 1327-1333, 2004.
25. CARRETTE O, BURKHARD PR, SANCHEZ JC, HOCHSTRASSER DF: State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics research. Nat Protoc 1: 812-823, 2006.
26. CHEN HS, REJTAR T, ANDREEV V, MOSKOVETS E, KARGER BL: High-speed, high-resolution monolithic capillary LC-MALDI MS using an off-line continuous deposition interface for proteomic analysis. Anal Chem 77: 2323-2331, 2005.
27. CHEVALLET M, LUCHE S, DIEMER H, STRUB JM, VAN DORSSELAER A, RABILLOUD T: Sweet silver: A formaldehyde-free silver staining using aldoses as developing agents, with enhanced compatibility with mass spectrometry. Proteomics 8: 4853-4861, 2008.
28. CHROMY BA, GONZALES AD, PERKINS J, CHOI MW, CORZETT MH, CHANG BC, CORZETT CH, MCCUTCHEN-MALONEY SL: Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins. J Proteome Res 3: 1120-1127, 2004.
29. CLAUSER KR, BAKER P, BURLINGAME AL: Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal Chem 71: 2871-2882, 1999.
30. COLLINS FS, LANDER ES, ROGERS J, WATERSTON RH: Finishing the euchromatic sequence of the human genome. Nature 431: 931-945, 2004.
31. COMEGYS MM, LIN SH, RAND D, BRITT D, FLANAGAN D, CALLANAN H, BRILLIANT K, HIXSON DC: Two variable regions in carcinoembryonic antigen-related cell adhesion molecule1 N-terminal domains located in or next to monoclonal antibody and adhesion epitopes show evidence of recombination in rat but not in human. J Biol Chem 279: 35063-35078, 2004.
32. COX J, MANN M: High peptide identification rates and proteome-wide quantitation via novel computational strategies. Nat Biotechnol 26: 1367-1372, 2008.
33. DATTELBAUM AM, IYER S: Surface-assisted laser desorption/ionization mass spectrometry. Expert Rev Proteomics 3: 153-161, 2006.
34. DESOUZA LV, ROMASCHIN AD, COLGAN TJ, SIU KW: Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. Anal Chem 81: 3462-3470, 2009.
35. DESOUZA LV, TAYLOR AM, LI W, MINKOFF MS, ROMASCHIN AD, COLGAN TJ, SIU KW: Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J Proteome Res 7: 3525-3534, 2008.
36. DOMON B, AEBERSOLD R: Mass spectrometry and protein analysis. Science 312: 212-217, 2006.
37. ECHAN LA, TANG HY, ALI-KHAN N, LEE K, SPEICHER DW: Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 5: 3292-3303, 2005.
38. ESSADER AS, CARGILE BJ, BUNDY JL, STEPHENSON JL JR: A comparison of immobilized pH gradient isoelectric focusing and strong-cation-exchange chromatography as a first dimension in shotgun proteomics. Proteomics 5: 24-34, 2005.
39. ETZIONI R, URBAN N, RAMSEY S, MCINTOSH M, SCHWARTZ S, REID B, RADICH J, ANDERSON G, HARTWELL L: The case for early detection. Nat Rev Cancer 3: 243-252, 2003.
40. FACA VM, SONG KS, WANG H, ZHANG Q, KRASNOSELSKY AL, NEWCOMB LF, PLENTZ RR, GURUMURTHY S, REDSTON MS, PITTERI SJ, PEREIRA-FACA SR, IRETON RC, KATAYAMA H, GLUKHOVA V, PHANSTIEL D, BRENNER DE, ANDERSON MA, MISEK D, SCHOLLER N, URBAN ND, BARNETT MJ, EDELSTEIN C, GOODMAN GE, THORNQUIST MD, McINTOSH MW, DEPINHO RA, BARDEESY N, HANASH SM: A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5: e123, 2008.
41. FIEDLER GM, LEICHTLE AB, KASE J, BAUMANN S, CEGLAREK U, FELIX K, CONRAD T, WITZIGMANN H, WEIMANN A, SCHUTTE C, HAUSS J, BUCHLER M, THIERY J: Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin Cancer Res 15: 3812-3819, 2009.
42. FINDEISEN P, ZAPATKA M, PECCERELLA T, MATZK H, NEUMAIER M, SCHADENDORF D, UGUREL S: Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. J Clin Oncol 27: 2199-2208, 2009.
43. GILAR M, OLIVOVA P, CHAKRABORTY AB, JAWORSKI A, GEROMANOS SJ, GEBLER JC: Comparison of 1-D and 2-D LC MS/MS methods for proteomic analysis of human serum. Electrophoresis 30: 1157-1167, 2009.
44. GOLDMAN R, RESSOM HW, ABDEL-HAMID M, GOLDMAN L, WANG A, VARGHESE RS, AN Y, LOFFREDO CA, DRAKE SK, EISSA SA, GOUDA I, EZZAT S, MOISEIWITSCH FS: Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum. Carcinogenesis 28: 2149-2153, 2007.
45. GOLDMAN R, RESSOM HW, VARGHESE RS, GOLDMAN L, BASCUG G, LOFFREDO CA, ABDEL-HAMID M, GOUDA I, EZZAT S, KYSELOVA Z, MECHREF Y, NOVOTNY MV: Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 15: 1808-1813, 2009.
46. GORG A, WEISS W, DUNN MJ: Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665-3685, 2004.
47. GOVORUKHINA NI, DE VRIES M, REIJMERS TH, HORVATOVICH P, VAN DER ZEE AG, BISCHOFF R: Influence of clotting time on the protein composition of serum samples based on LC-MS data. J Chromatogr B Analyt Technol Biomed Life Sci 877: 1281-1291, 2009.
48. GRAMOLINI AO, KISLINGER T, ALIKHANI-KOOPAEI R, FONG V, THOMPSON NJ, ISSERLIN R, SHARMA P, OUDIT GY, TRIVIERI MG, FAGAN A, KANNAN A, HIGGINS DG, HUEDIG H, HESS G, ARAB S, SEIDMAN JG, SEIDMAN CE, FREY B, PERRY M, BACKX PH, LIU PP, MacLENNAN DH, EMILI A: Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol Cell Proteomics 7: 519-533, 2008.
49. GUO Y, FU Z, VAN EYK JE: A proteomic primer for the clinician. Proc Am Thorac Soc 4: 9-17, 2007.
50. GYGI SP, RIST B, GERBER SA, TURECEK F, GELB MH, AEBERSOLD R: Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999, 1999.
51. HANASH SM, PITTERI SJ, FACA VM: Mining the plasma proteome for cancer biomarkers. Nature 452: 571-579, 2008.
52. HASHIGUCHI T, TANAKA K, LEE LJ, SASAKI K, NATSUGOE S, KAWAHARA KI, ARIMURA K, MARUYAMA I: Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis. Med Hypotheses 73: 760-763, 2009.
53. HAVLIS J, SHEVCHENKO A: Absolute quantification of proteins in solutions and in polyacrylamide gels by mass spectrometry. Anal Chem 76: 3029-3036, 2004.
54. HELLER M, MATTOU H, MENZEL C, YAO X: Trypsin catalyzed 16O-to-18O exchange for comparative proteomics: tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers. J Am Soc Mass Spectrom 14: 704-718, 2003.
55. HENZEL WJ, WATANABE C, STULTS JT: Protein identification: the origins of peptide mass fingerprinting. J Am Soc Mass Spectrom 14: 931-942, 2003.
56. HOFFMAN SA, JOO WA, ECHAN LA, SPEICHER DW: Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J Chromatogr B Analyt Technol Biomed Life Sci 849: 43-52, 2007.
57. HONGSACHART P, HUANG-LIU R, SINCHAIKUL S, PAN FM, PHUTRAKUL S, CHUANG YM, YU CJ, CHEN ST: Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Electrophoresis 30: 1206-1220, 2009.
58. HOOFNAGLE AN, BECKER JO, WENER MH, HEINECKE JW: Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 54: 1796-1804, 2008.
59. HU S, LOO JA, WONG DT: Human body fluid proteome analysis. Proteomics 6: 6326-6353, 2006.
60. HUANG HL, STASYK T, MORANDELL S, MOGG M, SCHREIBER M, FEUERSTEIN I, HUCK CW, STECHER G, BONN GK, HUBER LA: Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditions. Electrophoresis 26: 2843-2849, 2005a.
61. HUANG L, FANG X: Immunoaffinity fractionation of plasma proteins by chicken IgY antibodies. Methods Mol Biol 425: 41-51, 2008.
62. HUANG L, HARVIE G, FEITELSON JS, GRAMATIKOFF K, HEROLD DA, ALLEN DL, AMUNNGAMA R, HAGLER RA, PISANO MR, ZHANG WW, FANG X: Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis. Proteomics 5: 3314-3328, 2005b.
63. ISHIHAMA Y, ODA Y, TABATA T, SATO T, NAGASU T, RAPPSILBER J, MANN M: Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272, 2005.
64. KESHISHIAN H, ADDONA T, BURGESS M, KUHN E, CARR SA: Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 6: 2212-2229, 2007.
65. KESHISHIAN H, ADDONA T, BURGESS M, MANI DR, SHI X, KUHN E, SABATINE MS, GERSZTEN RE, CARR SA: Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 8: 2339-2349, 2009.
66. KIM HJ, KANG HJ, LEE H, LEE ST, YU MH, KIM H, LEE C: Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res 8: 1368-1379, 2009.
67. KINGSMORE SF: Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 5: 310-320, 2006.
68. KITTERINGHAM NR, JENKINS RE, LANE CS, ELLIOTT VL, PARK BK: Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 877: 1229-1239, 2009.
69. KUI WONG N, EASTON RL, PANICO M, SUTTON-SMITH M, MORRISON JC, LATTANZIO FA, MORRIS HR, CLARK GF, DELL A, PATANKAR MS: Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J Biol Chem 278: 28619-28634, 2003.
70. KULASINGAM V, DIAMANDIS EP: Tissue culture-based breast cancer biomarker discovery platform. Int J Cancer 123: 2007-2012, 2008.
71. KYSELOVA Z, MECHREF Y, KANG P, GOETZ JA, DOBROLECKI LE, SLEDGE GW, SCHNAPER L, HICKEY RJ, MALKAS LH, NOVOTNY MV: Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem 54: 1166-1175, 2008.
72. LAEMMLI UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
73. LANGE V, PICOTTI P, DOMON B, AEBERSOLD R: Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4: 222, 2008.
74. LAU TK, LEUNG TN: Genetic screening and diagnosis. Curr Opin Obstet Gynecol 17: 163-169, 2005.
75. LIU T, QIAN WJ, CHEN WN, JACOBS JM, MOORE RJ, ANDERSON DJ, GRITSENKO MA, MONROE ME, THRALL BD, CAMP DG 2ND, SMITH RD: Improved proteome coverage by using high efficiency cysteinyl peptide enrichment: the human mammary epithelial cell proteome. Proteomics 5: 1263-1273, 2005.
76. LIU T, QIAN WJ, MOTTAZ HM, GRITSENKO MA, NORBECK AD, MOORE RJ, PURVINE SO, CAMP DG 2ND, SMITH RD: Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics 5: 2167-2174, 2006.
77. LOOI KS, NAKAYASU ES, DIAZ RA, TAN EM, ALMEIDA IC, ZHANG JY: Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res 7: 4004-4012, 2008.
78. LUDWIG JA, WEINSTEIN JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856, 2005.
79. MACKINTOSH JA, CHOI HY, BAE SH, VEAL DA, BELL PJ, FERRARI BC, VAN DYK DD, VERRILLS NM, PAIK YK, KARUSO P: A fluorescent natural product for ultra sensitive detection of proteins in one-dimensional and two-dimensional gel electrophoresis. Proteomics 3: 2273-2288, 2003.
80. MANN M, WILM M: Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem 66: 4390-4399, 1994.
81. MATSUO EI, WATANABE M, KUYAMA H, NISHIMURA O: A new strategy for protein biomarker discovery utilizing 2-nitrobenzenesulfenyl (NBS) reagent and its applications to clinical samples. J Chromatogr B Analyt Technol Biomed Life Sci 877: 2607-2614, 2009.
82. MECHREF Y, MADERA M, NOVOTNY MV: Glycoprotein enrichment through lectin affinity techniques. Methods Mol Biol 424: 373-396, 2008.
83. MILLER I, CRAWFORD J, GIANAZZA E: Protein stains for proteomic applications: which, when, why? Proteomics 6: 5385-5408, 2006.
84. MITULOVIC G, MECHTLER K: HPLC techniques for proteomics analysis-a short overview of latest developments. Brief Funct Genomic Proteomic 5: 249-260, 2006.
85. NESVIZHSKII AI: Protein identification by tandem mass spectrometry and sequence database searching. Methods Mol Biol 367: 87-120, 2006.
86. NEUHOFF V, AROLD N, TAUBE D, EHRHARDT W: Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9: 255-262, 1988.
87. O'FARRELL PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021, 1975.
88. OMENN GS, STATES DJ, ADAMSKI M, BLACKWELL TW, MENON R, HERMJAKOB H, APWEILER R, HAAB BB, SIMPSON RJ, EDDES JS, KAPP EA, MORITZ RL, CHAN DW, RAI AJ, ADMON A, AEBERSOLD R, ENG J, HANCOCK WS, HEFTA SA, MEYER H, PAIK YK, YOO JS, PING P, POUNDS J, ADKINS J, QIAN X, WANG R, WASINGER V, WU CY, ZHAO X, ZENG R, ARCHAKOV A, TSUGITA A, BEER I, PANDEY A, PISANO M, ANDREWS P, TAMMEN H, SPEICHER DW, HANASH SM: Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5: 3226-3245, 2005.
89. ONG SE, BLAGOEV B, KRATCHMAROVA I, KRISTENSEN DB, STEEN H, PANDEY A, MANN M: Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386, 2002.
90. PAPPIN DJ, HOJRUP P, BLEASBY AJ: Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3: 327-332, 1993.
91. PIERCE A, UNWIN RD, EVANS CA, GRIFFITHS S, CARNEY L, ZHANG L, JAWORSKA E, LEE CF, BLINCO D, OKONIEWSKI MJ, MILLER CJ, BITTON DA, SPOONCER E, WHETTON AD: Eight-channel iTRAQ enables comparison of the activity of 6 leukaemogenic tyrosine kinases. Mol Cell Proteomics 7: 853-863, 2008.
92. POON TC: Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics 4: 51-65, 2007.
93. PUTZ S, REINDERS J, REINDERS Y, SICKMANN A: Mass spectrometry-based peptide quantification: applications and limitations. Expert Rev Proteomics 2: 381-392, 2005.
94. QUINTANA LF, CAMPISTOL JM, ALCOLEA MP, BANON-MANEUS E, SOL-GONZALEZ A, CUTILLAS PR: Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics 8: 1658-1673, 2009.
95. RABILLOUD T, VUILLARD L, GILLY C, LAWRENCE JJ: Silver-staining of proteins in polyacrylamide gels: a general overview. Cell Mol Biol (Noisy-le-grand) 40: 57-75, 1994.
96. RAI AJ, GELFAND CA, HAYWOOD BC, WARUNEK DJ, YI J, SCHUCHARD MD, MEHIGH RJ, COCKRILL SL, SCOTT GB, TAMMEN H, SCHULZ-KNAPPE P, SPEICHER DW, VITZTHUM F, HAAB BB, SIEST G, CHAN DW: HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5: 3262-3277, 2005.
97. RIFAI N, GILLETTE MA, CARR SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24: 971-983, 2006.
98. RIGHETTI PG, BOSCHETTI E: Sherlock Holmes and the proteome-a detective story. FEBS J 274: 897-905, 2007.
99. RIGHETTI PG, BOSCHETTI E, LOMAS L, CITTERIO A: Protein Equalizer Technology: the quest for a "democratic proteome". Proteomics 6: 3980-3992, 2006.
100. ROSA DD, ISMAEL G, LAGO LD, AWADA A: Molecular-targeted therapies: lessons from years of clinical development. Cancer Treat Rev 34: 61-80, 2008.
101. ROSS PL, HUANG YN, MARCHESE JN, WILLIAMSON B, PARKER K, HATTAN S, KHAINOVSKI N, PILLAI S, DEY S, DANIELS S, PURKAYASTHA S, JUHASZ P, MARTIN S, BARTLET-JONES M, HE F, JACOBSON A, PAPPIN DJ: Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169, 2004.
102. ROUX-DALVAI F, GONZALEZ DE PEREDO A, SIMO C, GUERRIER L, BOUYSSIE D, ZANELLA A, CITTERIO A, BURLET-SCHILTZ O, BOSCHETTI E, RIGHETTI PG, MONSARRAT B: Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics 7: 2254-2269, 2008.
103. SCHIESS R, WOLLSCHEID B, AEBERSOLD R: Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 3: 33-44, 2009.
104. SCHIRLE M, HEURTIER MA, KUSTER B: Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics 2: 1297-1305, 2003.
105. SCHMIDT A, KELLERMANN J, LOTTSPEICH F: A novel strategy for quantitative proteomics using isotope-coded protein labels. Proteomics 5: 4-15, 2005.
106. SCHNOLZER M, JEDRZEJEWSKI P, LEHMANN WD: Protease-catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 17: 945-953, 1996.
107. SCHRODER FH, HUGOSSON J, ROOBOL MJ, TAMMELA TL, CIATTO S, NELEN V, KWIATKOWSKI M, LUJAN M, LILJA H, ZAPPA M, DENIS LJ, RECKER F, BERENGUER A, MAATTANEN L, BANGMA CH, AUS G, VILLERS A, REBILLARD X, Van der KWAST T, BLIJENBERG BG, MOSS SM, De KONING HJ, AUVINEN A: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360: 1320-1328, 2009.
108. SENNELS L, SALEK M, LOMAS L, BOSCHETTI E, RIGHETTI PG, RAPPSILBER J: Proteomic analysis of human blood serum using peptide library beads. J Proteome Res 6: 4055-4062, 2007.
109. SHAH SJ, YU KH, SANGAR V, PARRY SI, BLAIR IA: Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry. J Proteome Res 8: 2407-2417, 2009.
110. SHEVCHENKO A, JENSEN ON, PODTELEJNIKOV AV, SAGLIOCCO F, WILM M, VORM O, MORTENSEN P, SHEVCHENKO A, BOUCHERIE H, MANN M: Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci USA 93: 14440-14445, 1996.
111. SPIRO RG: Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12: 43R-56R, 2002.
112. STATES DJ, OMENN GS, BLACKWELL TW, FERMIN D, ENG J, SPEICHER DW, HANASH SM: Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol 24: 333-338, 2006.
113. STESSL M, NOE CR, LACHMANN B: Influence of image-analysis software on quantitation of two-dimensional gel electrophoresis data. Electrophoresis 30: 325-328, 2009.
114. TAJIRI M, OHYAMA C, WADA Y: Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach. Glycobiology 18: 2-8, 2008.
115. TAM SW, PIRRO J, HINERFELD D: Depletion and fractionation technologies in plasma proteomic analysis. Expert Rev Proteomics 1: 411-420, 2004.
116. THIEDE B, HOHENWARTER W, KRAH A, MATTOW J, SCHMID M, SCHMIDT F, JUNGBLUT PR: Peptide mass fingerprinting. Methods 35: 237-247, 2005.
117. THOMPSON A, SCHAFER J, KUHN K, KIENLE S, SCHWARZ J, SCHMIDT G, NEUMANN T, JOHNSTONE R, MOHAMMED AK, HAMON C: Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 75: 1895-1904, 2003.
118. THULASIRAMAN V, LIN S, GHEORGHIU L, LATHROP J, LOMAS L, HAMMOND D, BOSCHETTI E: Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 26: 3561-3571, 2005.
119. TIAN Y, ZHOU Y, ELLIOTT S, AEBERSOLD R, ZHANG H: Solid-phase extraction of N-linked glycopeptides. Nat Protoc 2: 334-339, 2007.
120. TUCHOLSKA M, BOWDEN P, JACKS K, ZHU P, FURESZ S, DUMBROVSKY M, MARSHALL J: Human serum proteins fractionated by preparative partition chromatography prior to LC-ESI-MS/MS. J Proteome Res 8: 1143-1155, 2009.
121. TUMANI H, PFEIFLE M, LEHMENSIEK V, RAU D, MOGEL H, LUDOLPH AC, BRETTSCHNEIDER J: Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): Proteome analysis of cerebrospinal fluid. J Neuroimmunol 214: 109-112, 2009.
122. UNLU M, MORGAN ME, MINDEN JS: Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18: 2071-2077, 1997.
123. UNWIN RD, GRIFFITHS JR, WHETTON AD: A sensitive mass spectrometric method for hypothesis-driven detection of peptide post-translational modifications: multiple reaction monitoring-initiated detection and sequencing (MIDAS). Nat Protoc 4: 870-877, 2009.
124. VEENSTRA TD, CONRADS TP, HOOD BL, AVELLINO AM, ELLENBOGEN RG, MORRISON RS: Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 4: 409-418, 2005.
125. VILLANUEVA J, PHILIP J, ENTENBERG D, CHAPARRO CA, TANWAR MK, HOLLAND EC, TEMPST P: Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76: 1560-1570, 2004.
126. VILLANUEVA J, SHAFFER DR, PHILIP J, CHAPARRO CA, ERDJUMENT-BROMAGE H, OLSHEN AB, FLEISHER M, LILJA H, BROGI E, BOYD J, SANCHEZ-CARBAYO M, HOLLAND EC, CORDON-CARDO C, SCHER HI, TEMPST P: Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116: 271-284, 2006.
127. WADA Y, AZADI P, COSTELLO CE, DELL A, DWEK RA, GEYER H, GEYER R, KAKEHI K, KARLSSON NG, KATO K, KAWASAKI N, KHOO KH, KIM S, KONDO A, LATTOVA E, MECHREF Y, MIYOSHI E, NAKAMURA K, NARIMATSU H, NOVOTNY MV, PACKER NH, PERREAULT H, PETER-KATALINIC J, POHLENTZ G, REINHOLD VN, RUDD PM, SUZUKI A, TANIGUCHI N: Comparison of the methods for profiling glycoprotein glycans-HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 17: 411-422, 2007.
128. WASINGER VC, CORDWELL SJ, CERPA-POLJAK A, YAN JX, GOOLEY AA, WILKINS MR, DUNCAN MW, HARRIS R, WILLIAMS KL, HUMPHERY-SMITH I: Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16: 1090-1094, 1995.
129. WEI YS, ZHENG YH, LIANG WB, ZHANG JZ, YANG ZH, LV ML, JIA J, ZHANG L: Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer 112: 544-551, 2008.
130. WHITEAKER JR, ZHANG H, ZHAO L, WANG P, KELLY-SPRATT KS, IVEY RG, PIENING BD, FENG LC, KASARDA E, GURLEY KE, ENG JK, CHODOSH LA, KEMP CJ, MCINTOSH MW, PAULOVICH AG: Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J Proteome Res 6: 3962-3975, 2007.
131. WOLLSCHEID B, BAUSCH-FLUCK D, HENDERSON C, O'BRIEN R, BIBEL M, SCHIESS R, AEBERSOLD R, WATTS JD: Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol 27: 378-386, 2009.
132. WOLTERS DA, WASHBURN MP, YATES JR 3RD: An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73: 5683-5690, 2001.
133. WORKMAN P: The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones. Cancer Chemother Pharmacol 52 (Suppl 1): S45-S56, 2003.
134. XU G, XIANG CQ, LU Y, KANG XN, LIAO P, DING Q, ZHANG YF: Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Cancer Lett 282: 205-213, 2009.
135. YOUNG LS, SEARLE PF, ONION D, MAUTNER V: Viral gene therapy strategies: from basic science to clinical application. J Pathol 208: 299-318, 2006.
136. YU KH, BARRY CG, AUSTIN D, BUSCH CM, SANGAR V, RUSTGI AK, BLAIR IA: Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. J Proteome Res 8: 1565-1576, 2009.
137. ZHANG H, LIU AY, LORIAUX P, WOLLSCHEID B, ZHOU Y, WATTS JD, AEBERSOLD R: Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics 6: 64-71, 2007a.
138. ZHANG X, LI L, WEI D, YAP Y, CHEN F: Moving cancer diagnostics from bench to bedside. Trends Biotechnol 25: 166-173, 2007b.
139. ZINKIN NT, GRALL F, BHASKAR K, OTU HH, SPENTZOS D, KALMOWITZ B, WELLS M, GUERRERO M, ASARA JM, LIBERMANN TA, AFDHAL NH: Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 14: 470-477, 2008.